Starling Oncology Inc (TOI)Healthcare | Medical Care Facilities | Cerritos, United States |
USD
|
Hot Take ↕ | Oct. 10, 2026, 8:28 a.m. UTC
The immediate outlook is clouded by severe financial distress rather than momentum. The company is burning cash aggressively, with free cash flow and operating cash flow both deeply negative, while carrying debt significantly higher than its cash reserves. This imbalance creates a precarious liquidity situation where the business is consuming capital faster than it can generate it or access credit markets easily. Despite the 'strong buy' analyst consensus and recent insider buying, these actions likely reflect a desperate attempt to stabilize a failing operation rather than a sign of robust health. The stock has underperformed significantly over the last year, trading well below its 200-day average, which suggests the market has already priced in the deteriorating fundamentals. Without a proven path to profitability or a credible turnaround strategy that addresses the massive cash burn, the near-term risk of further downside or dilution remains high. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 5.537 |
| Market Cap | 512,912,480 |
| Forward P/E | -32.06 |
| Beta | 0.42 |
| Profit Margins | -7.97% |
| Website | https://theoncologyinstitute.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.5121951 |
| Address1 | 18,000 Studebaker Road |
| Address2 | Suite 800 |
| All Time High | 12.66 |
| All Time Low | 0.1253 |
| Ask | 6.31 |
| Ask Size | 200 |
| Audit Risk | 9 |
| Average Daily Volume10 Day | 1,970,151 |
| Average Volume | 1,991,815 |
| Average Volume10Days | 1,970,151 |
| Beta | 0.422 |
| Bid | 3.68 |
| Bid Size | 200 |
| Board Risk | 5 |
| Book Value | -0.163 |
| City | Cerritos |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Currency | USD |
| Current Price | 5.13 |
| Current Ratio | 1.473 |
| Date Short Interest | 1,784,073,600 |
| Day High | 5.15 |
| Day Low | 4.87 |
| Ebitda | -25,909,000 |
| Ebitda Margins | -0.047470003 |
| Enterprise To Ebitda | -22.677 |
| Enterprise To Revenue | 1.077 |
| Enterprise Value | 587,545,472 |
| Exchange | NCM |
| Exchange Timezone Name | UTC |
| Fifty Day Average | 5.3114 |
| Fifty Two Week High | 7.05 |
| Fifty Two Week Low | 2.32 |
| Financial Currency | USD |
| First Trade Date Epoch Utc | 1,784,295,000 |
| Float Shares | 86,668,206 |
| Forward Eps | -0.16 |
| Forward P E | -32.0625 |
| Free Cashflow | -15,312,625 |
| Full Time Employees | 641 |
| Fullday Change | 5.13 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 5.13 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.15117 |
| Gross Profits | 82,501,000 |
| Held Percent Insiders | 0.18415001 |
| Held Percent Institutions | 0.46043998 |
| Implied Shares Outstanding | 99,982,933 |
| Industry | Medical Care Facilities |
| Industry Disp | Medical Care Facilities |
| Industry Key | medical-care-facilities |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. |
| Long Name | Starling Oncology Inc |
| Market Cap | 512,912,480 |
| Max Age | 86,400 |
| Message Board Id | finmb_661363343 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -36,324,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 695,577,484 |
| Number Of Analyst Opinions | 5 |
| Open | 4.93 |
| Operating Cashflow | -21,814,000 |
| Operating Margins | -0.04417 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 562 735 3226 |
| Previous Close | 0.0 |
| Price Hint | 2 |
| Price To Sales Trailing12 Months | 0.9398064 |
| Profit Margins | -0.079730004 |
| Quick Ratio | 1.131 |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Regular Market Day High | 5.15 |
| Regular Market Day Low | 4.87 |
| Regular Market Open | 4.93 |
| Regular Market Previous Close | 0.0 |
| Regular Market Volume | 1,221,151 |
| Return On Assets | -0.122980006 |
| Revenue Growth | 0.412 |
| Revenue Per Share | 5.537 |
| Sand P52 Week Change | 0.1457566 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 99,982,933 |
| Shares Percent Shares Out | 0.0727 |
| Shares Short | 7,273,147 |
| Shares Short Previous Month Date | 1,781,481,600 |
| Shares Short Prior Month | 6,689,684 |
| Short Name | The Oncology Institute, Inc. |
| Short Percent Of Float | 0.083000004 |
| Short Ratio | 3.29 |
| State | CA |
| Symbol | TOI |
| Target High Price | 10.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 8.4 |
| Target Median Price | 8.0 |
| Time Zone Full Name | America/New_York |
| Time Zone Short Name | EDT |
| Total Cash | 30,280,000 |
| Total Cash Per Share | 0.303 |
| Total Debt | 104,913,000 |
| Total Revenue | 545,763,968 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Eps | -0.35 |
| Trailing Peg Ratio | None |
| Two Hundred Day Average | 3.87075 |
| Underlying Symbol | TOI |
| Uuid | 50f4e41b-d240-3030-8d48-ed0199bdd0cc |
| Volume | 1,221,151 |
| Website | https://theoncologyinstitute.com |
| Zip | 90,703 |